Genetic Signatures Ltd has released a press release.
Capital Raising Presentation
Filed with ASX ·
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Genetic Signatures Ltd. on 6ix
In the deck
Earlier from Genetic Signatures
- $6.9m R&D tax incentive received
- 2023 AGM Chairman's Address and CEO Presentation
- Quarterly update and Appendix 4C
- 510(k) Filing in Preparation for US Commercial Launch
- FDA 510(k) for Gastrointestinal Parasite Kit Submitted
Later from Genetic Signatures
- Genetic Signatures Announces $15.9m Capital Raising
- Genetic Signatures Successfully Completes Placement
- Genetic Signatures Rights Issue Offer Booklet
- 1H 24 Market Update
- TGA authorises supply of updated Respiratory Detection Kit
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures